Family Office Briefing on research bySavills·Apr 27, 2023
National Life Sciences State Of The Venture Capital Market & 2023 Outlook
U.S. life sciences venture capital funding dropped 28.2% in 2022 — family offices should consider co-GP opportunities in resilient sectors.
Life Science2023
Key Metrics
| Metric | Value |
|---|---|
| Venture Capital Funding Decline | 28.2% |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Savills
Building a thesis around Life Science? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.